1-4 of 4
Marta M. Lemos, MD
Close
Sort by
Journal Articles

Results of the Mantle Cell Lymphoma Subset from a Phase 2a Study of Copanlisib, a Novel PI3K Inhibitor, in Patients with Indolent and Aggressive Lymphoma

David Cunningham, Pier Luigi Zinzani, MD PhD, Sarit E. Assouline, MDMSc, Krimo Bouabdallah, MD, Dominique Bron, MD PhD, Corinne Haioun, MD PhD, Luigina Mollica, MD FRCPC, PhD, Marius Giurescu, MDPhD, Igor Gorbatchevsky, MD, Manoel Neves, MD, Marta M. Lemos, MD, Julia Grunert, PhD, Florian Hiemeyer, PhD, Barrett H. Childs, MD, Martin H. Dreyling, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3935.
https://doi.org/10.1182/blood.V126.23.3935.3935
Published: 2015
Journal Articles

Resource Use and Costs Associated With The Treatment Of Hematologic and NON-Hematologic Adverse Events In Chronic Myeloid Leukemia (CML) Brazilian Patients

Marcia Dias Alves, MBA, Marta M. Lemos, MD, Carla Boquimpani, MD
Journal: Blood
Blood (2013) 122 (21): 5620.
https://doi.org/10.1182/blood.V122.21.5620.5620
Published: 2013
Journal Articles

Number Needed to Treat (NNT) and Cost Estimation to Achieve a Major Molecular Response in Newly Diagnosed Chronic-phase cronic Myeloid Leukemia in Brasil: 24-months follow-up

Marcia Dias Alves, MBA, John Coombs, PharmD, MBA, Jefferson Ruiz, MD, Joice Valentim, PhD, Marta M. Lemos, MD
Journal: Blood
Blood (2011) 118 (21): 4216.
https://doi.org/10.1182/blood.V118.21.4216.4216
Published: 2011
Journal Articles

Number Needed to Treat (NNT) and Cost Estimation to Achieve a Major Molecular Response In Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia In Brazil

Marcia Dias Alves, MBA, John Coombs, PharmD, MBA, Jefferson Ruiz, MD, Joice Valentim, PhD, Marta M. Lemos, MD
Journal: Blood
Blood (2010) 116 (21): 1520.
https://doi.org/10.1182/blood.V116.21.1520.1520
Published: 2010